● EVA Air is the first Taiwanese airline to trial Affinidi’s digital verification solution to verify COVID-19 PCR Test Results
● Affinidi’s digital credentials ecosystem solution shortens the check-in and verification process for passengers while protecting data privacy.
SINGAPORE, 25 MARCH 2021 – Taiwan’sEVA Air and Affinidi, a Singapore-based technology company, today announced that the airline will be utilizing Affinidi’s digital credential verification solution in a pilot program with Singapore Changi Airport to verify passengers’ Polymerase Chain Reaction (PCR) test results for EVA’s Singapore toTaipei flights. The airline plans to extend this service to flights from Malaysia and Indonesia to Taipei and is evaluating the introduction of digital systems on other routes based on trial outcomes.
EVA is actively pursuing the development and deployment of digital verification platforms as part of its unwavering commitment to safeguarding the health and safety of passengers and crew members. Affinidi’s open, privacy-preserving and interoperable technology solution will enable airline ground staff to quickly and accurately determine the authenticity of PCR test results, including the name of the medical institution, date of the test and whether the passenger meets relevant policy requirements in their destination country.
“EVA upholds rigorous standards for safeguarding the health and safety of everyone traveling onboard our airline. We are pleased to be partnering Affinidi and Singapore Changi Airport on this digital verification platform trial which will offer greater peace of mind for our passengers, while ensuring the privacy of their health credentials,” said David Chen (Executive Vice President). “EVA is honored to be the only airline in Taiwan to be recognized as the “World’s TopTwenty COVID-19 Compliant Airlines”, and this pilot program underscores our continual efforts in enhancing measures to manage this pandemic.
”By using Affinidi’s digital verification solution, EVA expects to eliminate human errors stemming from individual interpretation of test results. This will not only improve the passenger experience at the airport, but also boost operational efficiency. Affinidi’s solution provides trusted assurance on the verification process and is able to read and authenticate health credentials of varying standards and formats from over 14 global providers.
Glenn Core, CEO of Affinidi, said: “Affinidi is committed to working with the aviation industry in building an ecosystem solution to address the increasingly complex environment for international travel as countries look to re-open their borders. We look forward to partnering EVA Air on this trial and to bringing greater convenience and confidence to travelers as we work towards our shared goal of making international travel safer for everyone.”
EVA has been working with airline and aviation industry organizations on establishing a reliable digital verification solution and promoting cross-border application standardization that will enable international systems to connect more seamlessly and support safe air travel. Currently, Singapore requires travelers to present QR codes for PCR test results from medical institutions, while Taiwan requires passengers to present a paper copy of their PCR test result when they check in for the flight.
International travel is likely to resume as COVID-19 vaccines are rolled out across the globe. Standardized digital health credentials verification systems will make it easier for travelers, airline ground staff and immigration officers to verify test results and vaccination records.
For media enquiries, contact: